Metastatic Triple Negative Breast Cancers
4 clinical trials · Condition
◉ Watch Metastatic Triple Negative Breast Cancers
| Record | Firm | Date |
|---|---|---|
| Selinexor & Talazoparib in Advanced Refractory Solid Tumors; Advanced/Metastatic Triple Negative Breast Cancer (START) (NCT05035745) | National University Hospital, Singapore | 2021-03-01 |
Track Metastatic Triple Negative Breast Cancers automatically
Every clearance here is in the API, with alerts when new ones post.